Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;55(2):131-160.
doi: 10.1358/dot.2019.55.2.2974962.

The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018

A I Graul  1 , C Dulsat  2 , P Pina  2 , E Cruces  2 , M Tracy  2
Affiliations
Review

The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018

A I Graul et al. Drugs Today (Barc). 2019 Feb.

Abstract

This eagle's-eye overview of the drug industry in 2018 provides insight into some of last year's top stories, including a large and still growing outbreak of Ebola in the Democratic Republic of the Congo, as well as the potential uses (and abuses) of CRISPR technology. As in previous years, we also review orphan drug development, new regulatory agency-supported programs such as Priority Medicines Scheme (PRIME) and Sakigake, pipeline attrition, and pharma/biotech mergers and acquisitions of note. Finally, we take a glimpse into the crystal ball to anticipate the new drugs that will be approved in 2019.

Keywords: CRISPR-Cas9; Ebola; Mergers and acquisitions; Orphan drugs; PRIME; Pipeline; Sakigake.

PubMed Disclaimer

Substances

LinkOut - more resources